Oculis Looks To Move Dry Eye Candidate To Phase III Despite Mixed Dataset

Dry eye disease
Oculis thinks its candidate can benefit a genetic subset of dry eye patients • Source: Shutterstock

More from Clinical Trials

More from R&D